Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
- Resource Type
- Article
- Authors
- Borazanci, E.; Schram, A.M.; Garralda, E.; Brana, I.; Vieito Villar, M.; Spreafico, A.; Oliva, M.; Lakhani, N.J.; Hoffman, K.; Hallett, R.M.; Maetzel, D.; Hua, F.; Hilbert, J.; Giblin, P.; Anido, J.; Kelly, A.; Vickers, P.J.; Wasserman, R.; Seoane, J.; Siu, L.L.; Hyman, D.M.; Hoff, D.V.; Tabernero, J.
- Source
- In ESMO Open August 2022 7(4)
- Subject
- Phase I Trials
- Language
- ISSN
- 2059-7029